Clinical application of AFP, CCL2 and HP in the diagnosis of liver metastasis from colorectal cancer

Abstract

Objective To compare the clinical value of alpha-fetoprotein (AFP), chemokine (C-C motif) ligand 2 (CCL2) and haptoglobin (HP) in the diagnosis of liver metastasis of colorectal cancer. Methods 256 patients with colorectal cancer in the 983rd Hospital of the Joint Service Support Force of PLAl from Jan. 2016 to Dec. 2018 and 92 healthy subjects (control group) were enrolled. The patients were grouped according to liver metastasis, including liver metastasis group (72 cases) and non-liver metastasis group (184 cases). The serum levels of AFP, CCL2 and HP in different groups were compared. The diagnostic values of AFP, CCL2 and HP in liver metastasis of colorectal cancer were analyzed by ROC curve. Results The serum concentrations of AFP, CCL2 and HP were increased in the control group, non-liver metastasis group and liver metastasis group in order, and the diffences between any two groups were statistically significant (all P 0.05). The difference in CEA between two experimental groups was not statistically significant (P>0.05). The results of diagnostic efficacy for colorectal cancer liver metastases showed that AFP+CCL2+HP had the highest sensitivity (93.05%), HP had the highest specificity (92.75%), CCL2+HP had the hightest Judden index (0.80), HP had the highest positive predictive rate (75.60%), and AFP+CCL2+HP had the hightest negative predictive rate (97.92%). Conclusions Early diagnosis and prevention of liver metastasis of colorectal cancer can improve the long-term survival rate of patients with colorectal cancer. HP, CCL2 and AFP have important clinical value in early diagnosis of liver metastasis of colorectal cancer. Key words: Colorectal neoplasms; Liver metastasis; Alpha-fetoprotein; Chemokine (C-C motif) ligand 2; Haptoglobin